CO5690602A2 - Regimenes anticonceptivos trifasicos extendidos - Google Patents
Regimenes anticonceptivos trifasicos extendidosInfo
- Publication number
- CO5690602A2 CO5690602A2 CO06037928A CO06037928A CO5690602A2 CO 5690602 A2 CO5690602 A2 CO 5690602A2 CO 06037928 A CO06037928 A CO 06037928A CO 06037928 A CO06037928 A CO 06037928A CO 5690602 A2 CO5690602 A2 CO 5690602A2
- Authority
- CO
- Colombia
- Prior art keywords
- progestin
- estrogen
- anticonceptive
- regimes
- extended
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
1.- Un método de anticoncepción que comprende los pasos de: administrar a una mujer de edad fértil una combinación de un estrógeno y una progestina durante al menos 42 días consecutivos seguido de un período libre de hormonas de 4 a 8 días, dicho estrógeno y progestina son administrados en una dosificación diaria anticonceptivamente efectiva durante una secuencia de por lo menos dos ciclos de al menos 21 días, en donde la dosificación de estrógeno permanece constante durante cada ciclo y la dosificación de progestina incrementa en las tres fases durante cada ciclo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50753603P | 2003-10-01 | 2003-10-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5690602A2 true CO5690602A2 (es) | 2006-10-31 |
Family
ID=34421627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO06037928A CO5690602A2 (es) | 2003-10-01 | 2006-04-21 | Regimenes anticonceptivos trifasicos extendidos |
Country Status (14)
Country | Link |
---|---|
US (1) | US20050090475A1 (es) |
EP (1) | EP1673094A1 (es) |
JP (1) | JP2007507534A (es) |
KR (1) | KR20060129175A (es) |
CN (1) | CN1863537A (es) |
AU (1) | AU2004277998A1 (es) |
BR (1) | BRPI0414945A (es) |
CA (1) | CA2540697A1 (es) |
CO (1) | CO5690602A2 (es) |
NO (1) | NO20061937L (es) |
NZ (1) | NZ545969A (es) |
RU (1) | RU2006114791A (es) |
WO (1) | WO2005032558A1 (es) |
ZA (1) | ZA200603416B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5898032A (en) | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
CN100581550C (zh) | 2001-12-05 | 2010-01-20 | 杜拉美德药物有限公司 | 预防怀孕和减少经期前症状的口服避孕药 |
JP2006525358A (ja) | 2003-05-02 | 2006-11-09 | ドゥラメド ファーマシューティカルズ, インコーポレイテッド | 長期周期避妊養生法を利用するホルモン治療の方法 |
NZ545130A (en) | 2003-07-16 | 2009-03-31 | Duramed Pharmaceuticals Inc | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
US20070111975A1 (en) * | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
TW200626161A (en) * | 2004-10-07 | 2006-08-01 | Duramed Pharmaceuticals Inc | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |
WO2007106264A2 (en) * | 2006-03-02 | 2007-09-20 | Warner Chilcott Company, Inc. | Extended cycle multiphasic oral contraceptive method |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US36247A (en) * | 1862-08-19 | Improvement in car-couplings | ||
US4264575A (en) * | 1979-07-16 | 1981-04-28 | Eli Lilly And Company | Contraceptive methods and compositions |
US4390531A (en) * | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
US5208225A (en) * | 1986-02-27 | 1993-05-04 | Warner-Lambert Company | Compositions containing fixed combinations |
US4762717A (en) * | 1986-03-21 | 1988-08-09 | The General Hospital Corporation | Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive |
US5108995A (en) * | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
US5043331A (en) * | 1989-06-15 | 1991-08-27 | Orion-Yhtyma Oy | Treatment of postmenopausal disorders |
DE3929376C1 (es) * | 1989-09-05 | 1991-04-18 | E.I. Du Pont De Nemours And Co., Wilmington, Del., Us | |
IE62665B1 (en) * | 1990-12-17 | 1995-02-22 | Akzo Nv | Contraceptive regimen |
US5211952A (en) * | 1991-04-12 | 1993-05-18 | University Of Southern California | Contraceptive methods and formulations for use therein |
US5439913A (en) * | 1992-05-12 | 1995-08-08 | Schering Aktiengesellschaft | Contraception method using competitive progesterone antagonists and novel compounds useful therein |
DE4344463A1 (de) * | 1993-12-22 | 1995-06-29 | Schering Ag | Kombinationsprodukt zur Kontrazeption |
DE4411585A1 (de) * | 1994-03-30 | 1995-10-05 | Schering Ag | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
DE19513662A1 (de) * | 1995-04-08 | 1996-10-10 | Schering Ag | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
DE19525017A1 (de) * | 1995-06-28 | 1997-01-02 | Schering Ag | Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption |
US6506390B2 (en) * | 1996-06-25 | 2003-01-14 | Akzo Nobel | Progestogen-anti-progestogen regimens |
US5770226A (en) * | 1996-07-10 | 1998-06-23 | Wake Forest University | Combined pharmaceutical estrogen-androgen-progestin oral contraceptive |
US6479475B1 (en) * | 1996-07-26 | 2002-11-12 | Wyeth | Oral contraceptive |
US6451778B1 (en) * | 1996-07-26 | 2002-09-17 | Wyeth | Oral contraceptive |
DE19705229C2 (de) * | 1997-02-12 | 1999-04-15 | Hesch Rolf Dieter Prof Dr Med | Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
US5898032A (en) * | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
JP2001513566A (ja) * | 1997-08-27 | 2001-09-04 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 経口避妊における、エストロゲンと子宮内膜節約性プロゲスチンおよび子宮内膜萎縮性プロゲスチンとの組み合わせ物 |
DE19739916C2 (de) * | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
US6326392B1 (en) * | 1997-11-06 | 2001-12-04 | American Home Products Corporation | Anti-estrogen plus progestin containing oral contraceptives |
US6214815B1 (en) * | 1998-12-23 | 2001-04-10 | Ortho-Mcneil Pharmaceuticals, Inc. | Triphasic oral contraceptive |
US6329416B1 (en) * | 1999-05-04 | 2001-12-11 | American Home Products Corporation | Combination regimens using 3,3-substituted indoline derivatives |
US20020177580A1 (en) * | 2001-05-23 | 2002-11-28 | Van Beek Agatha Antonia Magdalena | Means and method for hormonal contraception |
US20030018018A1 (en) * | 2001-07-10 | 2003-01-23 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea |
-
2004
- 2004-09-30 KR KR1020067007018A patent/KR20060129175A/ko not_active Application Discontinuation
- 2004-09-30 NZ NZ545969A patent/NZ545969A/en not_active IP Right Cessation
- 2004-09-30 JP JP2006534189A patent/JP2007507534A/ja active Pending
- 2004-09-30 CN CNA2004800289124A patent/CN1863537A/zh active Pending
- 2004-09-30 EP EP04789490A patent/EP1673094A1/en not_active Withdrawn
- 2004-09-30 BR BRPI0414945-9A patent/BRPI0414945A/pt not_active IP Right Cessation
- 2004-09-30 AU AU2004277998A patent/AU2004277998A1/en not_active Abandoned
- 2004-09-30 CA CA002540697A patent/CA2540697A1/en not_active Abandoned
- 2004-09-30 WO PCT/US2004/032497 patent/WO2005032558A1/en active Application Filing
- 2004-09-30 RU RU2006114791/14A patent/RU2006114791A/ru not_active Application Discontinuation
- 2004-09-30 US US10/955,276 patent/US20050090475A1/en not_active Abandoned
-
2006
- 2006-04-21 CO CO06037928A patent/CO5690602A2/es not_active Application Discontinuation
- 2006-04-28 ZA ZA200603416A patent/ZA200603416B/en unknown
- 2006-05-02 NO NO20061937A patent/NO20061937L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20060129175A (ko) | 2006-12-15 |
EP1673094A1 (en) | 2006-06-28 |
RU2006114791A (ru) | 2007-11-27 |
NO20061937L (no) | 2006-06-29 |
US20050090475A1 (en) | 2005-04-28 |
JP2007507534A (ja) | 2007-03-29 |
NZ545969A (en) | 2008-07-31 |
AU2004277998A1 (en) | 2005-04-14 |
BRPI0414945A (pt) | 2006-11-07 |
WO2005032558A1 (en) | 2005-04-14 |
CN1863537A (zh) | 2006-11-15 |
ZA200603416B (en) | 2007-09-26 |
CA2540697A1 (en) | 2005-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5690602A2 (es) | Regimenes anticonceptivos trifasicos extendidos | |
AR051931A1 (es) | Metodos de tratamiento hormonal que utilizan regimenes de ciclos extendidos con dosis ascendentes | |
AR030737A1 (es) | Metodo de anticoncepcion y forma de administracion del mismo | |
AR024566A1 (es) | Administracion de esteroides androgenicos no orales a mujeres | |
EA200201000A1 (ru) | Гормон-заместительная терапия | |
NO986104L (no) | Progesteron-anti-progesteron regimer | |
EA200600964A1 (ru) | Фармацевтический препарат для непрерывного гормонального лечения в течение периода времени более длительного, чем 21-28 дней, включающий две композиции эстрогена и/или прогестина | |
ES2190472T3 (es) | Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno. | |
CY1105276T1 (el) | Τριφασικο στοματικο αντισυλληπτικο | |
CR7611A (es) | Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona | |
EA201200377A8 (ru) | Способ пероральной контрацепции у женщин, способ управления нежелательными кровотечениями и предназначенная для применения в этих способах фармацевтическая упаковка | |
CY1105370T1 (el) | Μεθοδος θepαπειας των κλιμακτηριακων διαταραχων στις εμμηνοπαυσιακες και μετεμμηνοπαυσιακες γυναικες | |
TR200100234T2 (tr) | Biyojen estrojensülfamatların hormon sübstitüsyon terapisinde kullanılması. | |
CR8010A (es) | Regimenes de contraceptivos transdermicos extendidos | |
CY1106374T1 (el) | Μεθοδος θepαπειας αντικαταστασης ορμονης και μορφη χορηγησης της | |
CY1111406T1 (el) | Χρηση βαλερικης οιστραδιολης ή οιστραδιολης σε συνδυασμο με διενογεστη για την απο του στοματος θεραπεια της αιμορραγιας λογω δυσλειτουργιας της μητρας με τη μορφη απο του στοματος αντισυλληψης | |
AR021623A1 (es) | Auxiliares acuosos para dar forma al cabello | |
AR039227A1 (es) | Terapia de reemplazo hormonal | |
DK1937274T3 (da) | Anvendelse af estradiolvalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blødning i enhed med en oral kontraception | |
AR039228A1 (es) | Terapia de reemplazo hormonal | |
NO20072687L (no) | Farmasoytisk prevensjonspreparat | |
AR039477A1 (es) | Terapia de reemplazo hormonal | |
RU2001131730A (ru) | Применение антипрогестогенов в комбинированной терапии | |
TH84327B (th) | การใช้และชุดสำเร็จรูปแอนโดรเจนสเตอรอยด์ (Androgenic Steriod) แบบที่ไม่ใช้รับประทานในสุภาพสตรี | |
ECSP993262A (es) | Nuevos regimen anticonceptivo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |